Literature DB >> 592595

[Bladder instillation of adriamycin in the treatment of bladder tumors. Report 1: Clinical results (author's transl)].

Y Ozaki.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 592595     DOI： 10.5980/jpnjurol1928.68.10_934

Source DB:  PubMed          Journal:  Nihon Hinyokika Gakkai Zasshi        ISSN： 0021-5287


× No keyword cloud information.
  11 in total

1.  Intravesical chemotherapy with 4'-epi-Adriamycin in patients with superficial bladder tumors.

Authors:  Y Matsumura; T Tsushima; Y Ozaki; J Yoshimoto; T Akagi; T Obama; Y Nasu; H Ohmori
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 2.  Intravesical chemotherapy in the United States. An overview.

Authors:  J T Spaulding
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

3.  Plasma pharmacokinetics of adriamycin after intrapleural administration.

Authors:  S Eksborg; A Lindfors; B J Cedermark
Journal:  Med Oncol Tumor Pharmacother       Date:  1984

4.  Sequential instillation therapy with mitomycin C and adriamycin for superficial bladder tumors.

Authors:  I Fukui; H Sekine; K Kihara; T Yamada; T Kawai; M Washizuka; D Ishiwata; K Oka; K Hosoda; S Ikegami
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

5.  Minimization of inflammation in the treatment of bladder tumors by intravesical instillation of adriamycin.

Authors:  Y Ohi; K Okamoto; T Kawabata; A Hanafusa; C Y Fai; T Kakinoki; M Kawahara; S Asechi; N Sakamoto; S Nagata
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

6.  Intravesical adriamycin chemotherapy in bladder cancer.

Authors:  Y Matsumura; Y Ozaki; H Ohmori
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Development and clinical application of an AFC regimen (adriamycin, futraful, cytosine arabinoside) for superficial bladder tumors.

Authors:  T Mishina; T Kobayashi; M Maegawa; M Nakao; S Nakagawa
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

8.  Bladder instillation of adriamycin in the treatment of bladder cancer.

Authors:  C H Huang; C P Chiang
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

9.  Intravesical instillation of adriamycin in the presence or absence of verapamil for the treatment of superficial bladder cancer: preliminary report of a collaborative study.

Authors:  Y Ohi; H Ohmori; T Shirahama; M Kawahara; Y Matsumura; T Tsushima; Y Ohashi
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

10.  Intravesical combination chemotherapy with mitomycin C and doxorubicin for superficial bladder cancer: a randomized trial of maintenance versus no maintenance following a complete response.

Authors:  I Fukui; K Kihara; H Sekine; Y Tachibana; T Kawai; D Ishiwata; H Oshima
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.